AHCPR WOULD REVIEW TRIALS TO SHOW CLINICAL AND COST-EFFICACY SUPERIORITY UNDER EVOLVING WYDEN PLAN; AHCPR WOULD ALSO HAVE CHIEF ROLE DISSEMINATING RESULTS
Executive Summary
HHS' Agency for Health Care Policy & Research would be charged with reviewing trials to show clinical superiority or superior cost effectiveness under an evolving legislative proposal from Rep. Wyden (D-Ore.).